[{"address1": "75 State Street", "address2": "Suite 100", "city": "Boston", "state": "MA", "zip": "02109", "country": "United States", "phone": "617 229 6499", "website": "https://www.finchtherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew P. Blischak J.D.", "age": 61, "title": "President, Secretary & CEO", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 558807, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James S. Sigler MBA", "age": 63, "title": "Executive Vice President of CMC", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.8, "open": 13.8, "dayLow": 13.65, "dayHigh": 13.85, "regularMarketPreviousClose": 13.8, "regularMarketOpen": 13.8, "regularMarketDayLow": 13.65, "regularMarketDayHigh": 13.85, "payoutRatio": 0.0, "beta": 1.159, "forwardPE": -0.6629431, "volume": 320, "regularMarketVolume": 320, "averageVolume": 2252, "averageVolume10days": 3080, "averageDailyVolume10Day": 3080, "bid": 13.7, "ask": 14.0, "bidSize": 715, "askSize": 880, "marketCap": 21918678, "fiftyTwoWeekLow": 10.15, "fiftyTwoWeekHigh": 15.85, "allTimeHigh": 675.0, "allTimeLow": 0.8, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 12.86554, "twoHundredDayAverage": 13.22842, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 34872664, "profitMargins": 0.0, "floatShares": 896192, "sharesOutstanding": 1605763, "sharesShort": 19195, "sharesShortPriorMonth": 10600, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.012, "heldPercentInsiders": 0.03402, "heldPercentInstitutions": 0.0, "shortRatio": 0.19, "shortPercentOfFloat": 0.0276, "impliedSharesOutstanding": 1605764, "bookValue": 8.855, "priceToBook": 1.541502, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -14167000, "trailingEps": -8.8, "forwardEps": -20.59, "lastSplitFactor": "1:30", "lastSplitDate": 1686528000, "enterpriseToEbitda": -1.788, "52WeekChange": 0.15966392, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 13.65, "recommendationKey": "none", "totalCash": 16035000, "totalCashPerShare": 9.986, "ebitda": -19506000, "totalDebt": 28989000, "quickRatio": 3.594, "currentRatio": 3.872, "totalRevenue": 0, "debtToEquity": 203.875, "revenuePerShare": 0.0, "returnOnAssets": -0.2189, "returnOnEquity": -0.67280996, "grossProfits": 0, "freeCashflow": -15963625, "operatingCashflow": -18055000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FNCH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "shortName": "Finch Therapeutics Group, Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1616160600000, "regularMarketChange": -0.15000057, "regularMarketDayRange": "13.65 - 13.85", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 2252, "fiftyTwoWeekLowChange": 3.5, "fiftyTwoWeekLowChangePercent": 0.3448276, "fiftyTwoWeekRange": "10.15 - 15.85", "fiftyTwoWeekHighChange": -2.2000008, "fiftyTwoWeekHighChangePercent": -0.1388013, "fiftyTwoWeekChangePercent": 15.966392, "epsTrailingTwelveMonths": -8.8, "epsForward": -20.59, "fiftyDayAverageChange": 0.78446007, "fiftyDayAverageChangePercent": 0.06097374, "twoHundredDayAverageChange": 0.42157936, "twoHundredDayAverageChangePercent": 0.031869214, "corporateActions": [], "regularMarketTime": 1763758800, "exchange": "PNK", "messageBoardId": "finmb_320858778", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.0869607, "regularMarketPrice": 13.65, "longName": "Finch Therapeutics Group, Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "displayName": "Finch Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]